Aprameya Engineering P/B Ratio
Current P/B Ratio
4.39
High Valuation
Very High - Significant premium, high growth expectations or speculative
Aprameya Engineering (APRAMEYA) P/B ratio is 4.39 (High), book value per share ₹36.32 vs Healthcare average P/B of -0.35 — Very High - Significant premium, high growth expectations or speculative. Compare with APRAMEYA fair value estimate to assess whether the stock is under or overvalued.
Current Valuation Metrics
P/B Ratio
4.39
Current Price
₹
Book Value/Share
₹36.32
Exchange
None
Book Value Breakdown (2026)
Balance Sheet Components
Total Equity
₹69 Cr
Share Capital
₹19 Cr
Reserves & Surplus
₹50 Cr
Outstanding Shares
19,000,000
Book Value per Share
₹36.32
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
-0.35
Sector Median
0.61
Sector Rank
#11 of 50
Sector Percentile
22.0%
APRAMEYA P/B Ratio — Valuation Insights & Book Value Analysis
Aprameya Engineering price-to-book ratio interpretation, valuation status and historical context — current P/B 4.39 (High). View Aprameya Engineering 52-week for the annual high/low range and current price position.
- Stock appears overvalued with PB of 4.39, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.35
APRAMEYA vs Healthcare Peers — P/B Ratio Comparison
Aprameya Engineering P/B 4.39 vs Healthcare average -0.35, median 0.61 — range -18.41–1.04.
Sector Average
-0.35
Sector Median
0.61
Lowest P/B
-18.41
Highest P/B
1.04
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Parmax Pharma | PARMAX | -3.24 | ₹23 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.6 | ₹53 | Low |